课题基金 / 基金详情

Molecular analysis of anti-apoptotic action in MALT lymphoma and its clinical application for diagnosis and treatment.

Molecular analysis of anti-apoptotic action in MALT lymphoma and its clinical application for diagnosis and treatment.
MALT淋巴瘤抗凋亡作用的分子分析及其临床诊断和治疗应用。
批准号:
17591023
负责人:
HOSOKAWA Yoshitaka
金额:
$2.24万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006

项目摘要

项目成果

HOSOKAWA Yoshitaka的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
API2-MALT1. t(11;18)(q21;q21) is a characteristic chromosomal translocation in mucosa-associated lymphoid tissue (MALT) type lymphoma, and this translocation results in chimeric transcript of API2 (Apoptosis Inhibitor 2, also known as c-IAP2)-MALT1 (Mucosa-Associated Lymphoma Translocation gene 1). To identify proteins that bind API2-MALT1 chimeric protein, we employed coimmunoprecipitation and SDS PAGE analysis, followed by liquid chromatography-electrospray ionization tandem mass spectrometry. As a result, Smac, Htra2, and TRAF2 were identified as API2-MALT1-binding proteins.Immunoprecipitation analysis demonstrated that ectopically expressed API2-MALT1 protein indeed binds to these endogeneous proteins. Furthermore, API2-MALT1 protein significantly inhibited Smac-promoted apoptosis in UV irradiated HeLa cells. These data strongly suggest that API2-MALT1 can block apoptosis, at least in part, by inhibiting Smac-mediated apoptotic pathway. Further study is warranted to investigate the detailed molecular mechanism of API2-MALT1 and its clinical application.
期刊论文(15)
专著(0)
科研奖励(0)
会议论文
Molecular pathogenesis of MALT lymphoma : two signaling pathways underlying the antiapoptotic of API2-MALT1 fusion protein
MALT淋巴瘤的分子发病机制:API2-MALT1融合蛋白抗凋亡的两条信号通路
DOI: --
发表时间: 2006
期刊: Leukemia 20
影响因子: --
作者: [Hamaguchi I, Morisada T, Azuma M, Murakami K, Kuramitsu M, Mizukami T, Ohbo K, Yamaguchi K, Oike Y, Dumont DJ, Suda T, Nakagawa M et al.]
通讯作者: Nakagawa M et al.
Molecular pathogenesis of MALT lymphoma : two signaling pathways underlying anti-apoptotic effect of API2-MALT1 fusion protein
MALT淋巴瘤的分子发病机制:API2-MALT1融合蛋白抗凋亡作用的两条信号通路
DOI: --
发表时间:
期刊: Leukemia (In press)
影响因子: --
作者: [Tsujimura K, et al., Nakagawa et al.]
通讯作者: Nakagawa et al.
Anti-apoptotic action of API2-MALT1 fusion protein involved in t(11;18)(q21;q21) MALT lymphoma.
API2-MALT1 融合蛋白参与 t(11;18)(q21;q21) MALT 淋巴瘤的抗凋亡作用。
DOI: --
发表时间: 2005
期刊: Apoptosis 10
影响因子: --
作者: [Hosokawa Y et al.]
通讯作者: Hosokawa Y et al.
API2-MALT1 fusion protein induces transcriptional activation of the API2 gene through NF-кB binding elements; evidence for a positive feed-back loop pathway resulting in unremitting NF-кB activation.
API2-MALT1 融合蛋白通过 NF-кB 结合元件诱导 API2 基因的转录激活;证据表明正反馈环路途径导致 NF-кB 持续激活。
DOI: --
发表时间: 2005
期刊: Biochem.Biophys.Res.Commun. 334
影响因子: --
作者: [Hosokawa Y, Suzuki H, Nakagawa M, Lee TH, Seto M.]
通讯作者: Seto M.
8
    Basic study of the bioactive substances of a skin of citrus fruits for periodontal disease treatment
    • 批准号:
      19K10151
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.75万
    • 财政年份:
      2019
    • 负责人:
      HOSOKAWA Yoshitaka
    • 依托单位:
    Analysis of leukocyte infiltration mechanism to participate in inflammatory bone resorption in periodontal lesion
    • 批准号:
      16K11834
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2016
    • 负责人:
      HOSOKAWA Yoshitaka
    • 依托单位:
    Analysis of Th17 cells migration and activation in periodontally diseased tissues
    • 批准号:
      25463219
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.16万
    • 财政年份:
      2013
    • 负责人:
      HOSOKAWA Yoshitaka
    • 依托单位:
    Analysis of Th17 cells migration inperiodontally diseased tissues.
    • 批准号:
      23792479
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.66万
    • 财政年份:
      2011
    • 负责人:
      HOSOKAWA Yoshitaka
    • 依托单位:
    国内基金
    海外基金
    Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
    • 批准号:
      LBY21H010001
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2020
    • 负责人:
      郑绪阳
    • 依托单位:
    去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
    • 批准号:
      31970691
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2019
    • 负责人:
      张胜萍
    • 依托单位:
    TM9SF4调控非小细胞肺癌细胞凋亡机制研究
    • 批准号:
      31900527
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      24.0万元
    • 批准年份:
      2019
    • 负责人:
      孙磊
    • 依托单位:
    基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
    • 批准号:
      81703335
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2017
    • 负责人:
      卫高菲
    • 依托单位: